Stock report · Delisted · Nasdaq
Cyclacel Pharmaceuticals Inc (CYCC)
6.37USD Delisted Final close · Sep 11, 2025
CYCC no longer trades. Cyclacel Pharmaceuticals was delisted from the Nasdaq in September 2025.
All prices on this page are historical. The last trade was on September 11, 2025, at $6.37.
CYCC stock price history
Final trading statistics
- Final close
- $6.37
- Final trading day
- Sep 11, 2025
- Market cap at delisting
- $14.25M
- Shares outstanding
- 2.24M
- Final 52-week range
- $0.17 – $19.87
- Avg. volume (final 3 mo.)
- 1,863,977
- All-time high
- $1000000.00 · Mar 2004
- All-time low
- $3.31 · Jul 2025
- Return since IPO
- -100.0%
- Beta
- 0.16
- Book value / share
- $2.29
- Price / book
- 2.78
About Cyclacel Pharmaceuticals Inc
Cyclacel Pharmaceuticals, Inc. was a clinical-stage biopharmaceutical company developing cancer drugs based on the biology of the cell cycle, transcription regulation, epigenetics and mitosis control. Its lead candidate, plogosertib, was in a Phase 1/2 trial for solid tumors and blood cancers. Founded in 1996, the company was based in Kuala Lumpur, Malaysia. Its stock was delisted from the Nasdaq in September 2025, with the last trade on September 11, 2025 at $6.37.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Kuala Lumpur
- Employees
- —
- IPO date
- May 5, 2004
- Delisted
- September 11, 2025
- SEC CIK
- 1130166
Cyclacel Pharmaceuticals financials before the delisting
The last 5 fiscal years Cyclacel Pharmaceuticals reported as a public company, fiscal year ending December.
CYCC revenue and net income
CYCC earnings per share
CYCC annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $43.0K | −$11.2M | — |
| FY2023 | $420.0K | −$22.6M | −$7.63 |
| FY2022 | $373.0K | −$21.2M | −$1.90 |
| FY2021 | $0.00 | −$18.9M | −$2.14 |
| FY2020 | $5.9K | −$8.4M | −$3.87 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Cyclacel Pharmaceuticals stock FAQ
What happened to Cyclacel Pharmaceuticals stock?
Cyclacel Pharmaceuticals was delisted from the Nasdaq in September 2025. The final close was $6.37 on September 11, 2025.
Can I still buy CYCC stock?
No. CYCC is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on September 11, 2025.
What was the last price of CYCC?
CYCC last closed at $6.37 on September 11, 2025, which valued the company at about $14.25M.
How did Cyclacel Pharmaceuticals do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Cyclacel Pharmaceuticals reported revenue of $43.0K and net income of −$11.2M.
When did Cyclacel Pharmaceuticals go public?
Cyclacel Pharmaceuticals shares started trading on May 5, 2004.
CYCC no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.